Questioner to cancer patients MSC-INHP-QCP1 (Questioner to cancer patients, Study MSC-INHP-8800)

11/03/2015
22/04/2015
EU PAS number:
EUPAS8800
Study
Ongoing
Study type

Study type

Not applicable

Scope of the study

Drug utilisation

If ‘Not applicable’, further details on the study type

Active surveillance
Study drug and medical condition

Medical condition to be studied

Non-Hodgkin's lymphoma
Colorectal cancer
Breast cancer
Renal cancer
Ovarian cancer
Glioblastoma
Population studied

Age groups

  • Children (2 to < 12 years)
  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

1000
Study design details

Main study objective

MSC-INHP 8800 is to measure current (baseline) standard care for cancer therapies, practices and expectations from the patient point of view while comparing standar cancer care, patient outcome in response to new drug developments "the Biosimilars" over 5 years.

Data analysis plan

Epidemiological methods shall be used for the analysis of the collected data.